Blood test to help diagnose ulcerative colitis
Part of Digestive system, Immune system & allergy clinical trials.
This trial will check if two substances in the blood, Oncostatin M and Galectin 3, can help doctors diagnose and tell how active ulcerative colitis is. It includes new patients with ulcerative colitis and healthy people for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been newly diagnosed with ulcerative colitis based on colonoscopy and biopsy
- You have not yet started treatment for ulcerative colitis
- You do not have other conditions like rheumatoid arthritis, asthma, cancer, or Crohn’s disease
- You are willing to have a blood test and answer questions about your symptoms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a substance in your urine can help measure how active your ulcerative colitis is. Researchers hope this simple urine test might become a useful tool to track your disease without more invasive procedures.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study looks at whether certain blood markers can help measure disease activity in people with Crohn's disease or ulcerative colitis. It involves reviewing medical records and may include a colonoscopy if you have one done as part of your routine care.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
This study looks for specific body signals (called mitochondrial “DAMPs”) that may reflect active inflammation in Crohn’s disease and ulcerative colitis. It also checks how these markers relate to what doctors see during colonoscopy or flexible scope exams, to help understand inflammation and potentially guide future care.
Hear when a new Ulcerative Colitis Disease Patients and Normal Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.